Position in LLY
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$5,505,645,627
+$1,392,638,384 QoQ
Shares Held
4,590,218
+2.6% QoQ
Ownership
0.488%
of shares outstanding
% of Portfolio
1.24%
of 13F equity value
Holder Rank
#32
of 4,605 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 99%
Shared 0%
None 1%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Derivatives in LLY
reported options exposure · as of Mar 31, 2024CallValue
$0
CallShares
0
PutValue
$22,794,228
PutShares
29,300
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026FRANKLIN RESOURCES INC holds $21,591,255,986 across 16 Drug Manufacturers - General names. LLY ranks #1 (25.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
4,590,218 | $5,505,645,627 | |
| 2 | ABBV |
AbbVie Inc.
|
19,925,232 | $5,013,985,374 | |
| 3 | AZN |
Astrazeneca PLC
|
16,511,727 | $3,130,953,667 | |
| 4 | JNJ |
Johnson & Johnson
|
10,086,602 | $2,561,694,303 | |
| 5 | MRK |
Merck & Co., Inc.
|
19,548,585 | $2,511,993,169 | |
| 6 | NVO |
Novo Nordisk A S
|
13,041,109 | $625,190,761 | |
| 7 | NVS |
Novartis AG
|
3,251,281 | $509,540,755 | |
| 8 | AMGN |
Amgen Inc
|
1,365,550 | $494,492,960 |
All Filings in LLY
Export CSV
27 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,505,645,627 | 4,590,218 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $4,113,007,243 | 4,471,778 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $4,963,194,021 | 4,618,299 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $3,693,063,444 | 4,840,188 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $3,715,914,265 | 4,766,865 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $3,470,580,354 | 4,202,129 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $2,773,660,128 | 3,592,824 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $3,220,867,644 | 3,635,537 | Shares | Defined | 2024-11-27 | |
| 2024-06-30 | $3,416,634,311 | 3,773,702 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $3,016,073,119 | 3,876,900 | Shares | Defined | 2024-05-13 | |
| 2024-03-31 | $22,794,228 | 29,300 | Put | Defined | 2024-05-13 | |
| 2023-12-31 | $1,353,655,073 | 2,322,197 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $1,292,966,979 | 2,407,177 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $1,495,217,039 | 3,188,232 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $1,192,547,239 | 3,472,562 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $1,050,434,558 | 2,871,295 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $789,118,858 | 2,440,448 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $840,924,220 | 2,593,604 | Shares | Defined | 2022-08-11 | |
| 2022-03-31 | $853,731,680 | 2,981,219 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $768,888,474 | 2,783,609 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $904,190,142 | 3,913,396 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $1,091,553,737 | 4,755,811 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $864,793,327 | 4,629,019 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $1,022,152,290 | 6,053,970 | Shares | Defined | 2021-02-10 | |
| 2020-09-30 | $723,973,217 | 4,891,050 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $821,805,121 | 5,005,513 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $834,648,135 | 6,016,783 | Shares | Defined | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||